1)Tomson T, et al : Declining malformation rates with changed antiepileptic drug prescribing : An observational study. Neurology 93 : e831-e840, 2019
2)加藤昌明 : 抗てんかん薬.伊藤真也,他(編) : 薬物治療コンサルテーション妊娠と授乳,改訂3版.pp529-548,南山堂,2020
3)加藤昌明 : てんかん.調剤と情報 25 : pp1060-1077, 2019
4)Kaneko S, et al : Congenital malformations due to antiepileptic drugs. Epilepsy Res 33 : 145-158, 1999
5)Tomson T, et al : Dose-dependent teratogenicity of valproate in mono- and polytherapy : an observational study. Neurology 85 : 866-872, 2015
6)Meador KJ, et al : Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years(NEAD study): a prospective observational study. Lancet Neurol 12 : 244-252, 2013
7)Christensen J, et al : Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 309 : 1696-1703, 2013
8)Christensen J, et al : Association of prenatal exposure to valproate and other antiepileptic drugs with risk for attention-deficit/hyperactivity disorder in offspring. JAMA Netw Open 2 : e186606, 2019
9)Sabers A : Algorithm for lamotrigine dose adjustment before, during, and after pregnancy. Acta Neurol Scand 126 : e1-e4, 2012